We previously showed that CCK-BR targeted NPs delivering a gastrin (GAST) siRNA payload could prevent pancreatic cancer metastases in mice bearing PANC-1 and BxPC-3 tumors when treatment with nanoparticles was initiated one week after tumor cell inoculation. This evidence concerns the gene CCKBR and familial pancreatic carcinoma.